DRUG-THERAPY - ACETAMINOPHEN

[1] ABEL JA, 1971, CLIN PHARMACOL THER, V12, P583

[2] Beaver W T, 1966, Am J Med Sci, V251, P576

[3] BEAVER WT, 1965, AM J MED SCI, V250, P577

[4] BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58

[5] CLARK R, 1973, LANCET, V1, P66

[6] CLARK WG, 1972, J PHARMACOL-PARIS, V181, P183

[7] DOUGLAS AP, 1976, LANCET, V1, P111

[8] EADE NR, 1967, J PHARMACOL EXP THER, V155, P301

[9] FARID NR, 1972, LANCET, V2, P396

[10] NEW ASPECTS OF MODE OF ACTION OF NONSTEROID ANTIINFLAMMATORY DRUGS [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 : 57 - 73

[1] ABEL JA, 1971, CLIN PHARMACOL THER, V12, P583

[2] Beaver W T, 1966, Am J Med Sci, V251, P576

[3] BEAVER WT, 1965, AM J MED SCI, V250, P577

[4] BRODIE BB, 1949, J PHARMACOL EXP THER, V97, P58

[5] CLARK R, 1973, LANCET, V1, P66

[6] CLARK WG, 1972, J PHARMACOL-PARIS, V181, P183

[7] DOUGLAS AP, 1976, LANCET, V1, P111

[8] EADE NR, 1967, J PHARMACOL EXP THER, V155, P301

[9] FARID NR, 1972, LANCET, V2, P396

[10] NEW ASPECTS OF MODE OF ACTION OF NONSTEROID ANTIINFLAMMATORY DRUGS [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 : 57 - 73